KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Accumulated Depreciation & Amortization: 2012-2014

Historic Accumulated Depreciation & Amortization for Biocryst Pharmaceuticals (BCRX) over the last 2 years, with Dec 2014 value amounting to $14.0 million.

  • Biocryst Pharmaceuticals' Accumulated Depreciation & Amortization fell 0.59% to $14.0 million in Q4 2014 from the same period last year, while for Dec 2014 it was $28.3 million, marking a year-over-year decrease of 1.13%. This contributed to the annual value of $1.2 million for FY2024, which is 24.71% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Accumulated Depreciation & Amortization of $14.0 million as of Q4 2014, which was down 0.59% from $14.1 million recorded in Q4 2013.
  • Biocryst Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $14.3 million during Q4 2012, with a 5-year trough of $86,000 in Q2 2013.
  • In the last 3 years, Biocryst Pharmaceuticals' Accumulated Depreciation & Amortization had a median value of $168,000 in 2012 and averaged $6.1 million.
  • Data for Biocryst Pharmaceuticals' Accumulated Depreciation & Amortization shows a maximum YoY tumbled of 45.22% (in 2013) over the last 5 years.
  • Over the past 3 years, Biocryst Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $14.3 million in 2012, then declined by 1.68% to $14.1 million in 2013, then declined by 0.59% to $14.0 million in 2014.
  • Its last three reported values are $14.0 million in Q4 2014, $14.1 million for Q4 2013, and $86,000 during Q2 2013.